Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
Title:
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
Author:
Olmos, D. Arkenau, H.-T. Ang, J.E. Ledaki, I. Attard, G. Carden, C.P. Reid, A.H.M. A'Hern, R. Fong, P.C. Oomen, N.B. Molife, R. Dearnaley, D. Parker, C. Terstappen, L.W.M.M. de Bono, J.S.